id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0809-0040,FDA,FDA-2026-N-0809,Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments; Reopening of the Comment Period,Notice,Request for Comments,2026-06-11T04:00:00Z,2026,6,2026-06-11T04:00:00Z,2026-03-04T04:59:59Z,2026-06-11T17:12:02Z,2026-11690,0,0,09000064b9324b04
FDA-2026-N-0809-0012,FDA,FDA-2026-N-0809,Request for Extension from Animal Health Institute,Other,Request for Extension,2026-05-06T04:00:00Z,2026,5,2026-05-06T04:00:00Z,,2026-05-06T22:33:24Z,,0,0,09000064b922f5f8
FDA-2026-N-0809-0001,FDA,FDA-2026-N-0809,Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments,Notice,Request for Comments,2026-03-03T05:00:00Z,2026,3,2026-03-03T05:00:00Z,2026-07-14T03:59:59Z,2026-07-14T09:00:18Z,2026-04196,0,0,09000064b91ed501